| # | Title | Journal | Year | Citations |
|---|
| 1 | ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma | International Journal of Gynecological Cancer | 2021 | 859 |
| 2 | ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up | International Journal of Gynecological Cancer | 2016 | 515 |
| 3 | Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG) | International Journal of Gynecological Cancer | 2011 | 500 |
| 4 | Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations—2019 update | International Journal of Gynecological Cancer | 2019 | 452 |
| 5 | New tumor markers: CA125 and beyond | International Journal of Gynecological Cancer | 2005 | 424 |
| 6 | 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer: Report From the Fourth Ovarian Cancer Consensus Conference | International Journal of Gynecological Cancer | 2011 | 361 |
| 7 | The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer | International Journal of Gynecological Cancer | 2018 | 336 |
| 8 | Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus | International Journal of Gynecological Cancer | 2002 | 279 |
| 9 | CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use | International Journal of Gynecological Cancer | 2005 | 257 |
| 10 | Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan | International Journal of Gynecological Cancer | 2007 | 254 |
| 11 | Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas | International Journal of Gynecological Cancer | 2002 | 252 |
| 12 | Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer | International Journal of Gynecological Cancer | 2010 | 244 |
| 13 | Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions | International Journal of Gynecological Cancer | 2003 | 241 |
| 14 | Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy | International Journal of Gynecological Cancer | 2003 | 240 |
| 15 | Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer: The Multicenter Intergroup Study DESKTOP II. A Project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO | International Journal of Gynecological Cancer | 2011 | 239 |
| 16 | A randomized study of screening for ovarian cancer: a multicenter study in Japan | International Journal of Gynecological Cancer | 2008 | 232 |
| 17 | Pathologic Ultrastaging Improves Micrometastasis Detection in Sentinel Lymph Nodes During Endometrial Cancer Staging | International Journal of Gynecological Cancer | 2013 | 223 |
| 18 | Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850) | International Journal of Gynecological Cancer | 2020 | 220 |
| 19 | Efficacy and safety of erlotinib HCl, an epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor, in patients with advanced ovarian carcinoma: results from a phase II multicenter study | International Journal of Gynecological Cancer | 2005 | 219 |
| 20 | Treatment goals in ovarian cancer | International Journal of Gynecological Cancer | 2005 | 219 |
| 21 | Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions | International Journal of Gynecological Cancer | 2003 | 205 |
| 22 | A nerve-sparing radical hysterectomy: Guidelines and feasibility in Western patients | International Journal of Gynecological Cancer | 2001 | 199 |
| 23 | The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment | International Journal of Gynecological Cancer | 2001 | 198 |
| 24 | Human papillomavirus infection: biology, epidemiology, and prevention | International Journal of Gynecological Cancer | 2005 | 198 |
| 25 | Gynecologic Cancers in Pregnancy: Guidelines of a Second International Consensus Meeting | International Journal of Gynecological Cancer | 2014 | 198 |
| 26 | Expression of CD133-1 and CD133-2 in ovarian cancer | International Journal of Gynecological Cancer | 2008 | 195 |
| 27 | Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers | International Journal of Gynecological Cancer | 2016 | 195 |
| 28 | Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy | International Journal of Gynecological Cancer | 2003 | 191 |
| 29 | Clinical Trials in Recurrent Ovarian Cancer | International Journal of Gynecological Cancer | 2011 | 186 |
| 30 | The Fallopian Tube: Primary Site of Most Pelvic High-grade Serous Carcinomas | International Journal of Gynecological Cancer | 2009 | 181 |
| 31 | The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology | International Journal of Gynecological Cancer | 2008 | 169 |
| 32 | SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer | International Journal of Gynecological Cancer | 2020 | 169 |
| 33 | Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study | International Journal of Gynecological Cancer | 2007 | 168 |
| 34 | Human papillomavirus type distribution in women from Asia: a meta-analysis | International Journal of Gynecological Cancer | 2008 | 167 |
| 35 | Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease | International Journal of Gynecological Cancer | 2008 | 167 |
| 36 | ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease | International Journal of Gynecological Cancer | 2019 | 167 |
| 37 | Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel | International Journal of Gynecological Cancer | 2000 | 166 |
| 38 | Resection of bulky positive lymph nodes in patients with cervical carcinoma | International Journal of Gynecological Cancer | 1995 | 163 |
| 39 | Distant metastases in ovarian carcinoma | International Journal of Gynecological Cancer | 2003 | 160 |
| 40 | ATL | International Journal of Gynecological Cancer | 2014 | 156 |
| 41 | Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later | International Journal of Gynecological Cancer | 2001 | 154 |
| 42 | Risk-Reducing Salpingo-Oophorectomy (RRSO) in BRCA Mutation Carriers | International Journal of Gynecological Cancer | 2011 | 154 |
| 43 | Hormone therapy in advanced and recurrent endometrial cancer: a systematic review | International Journal of Gynecological Cancer | 2007 | 153 |
| 44 | Uterine Leiomyosarcoma: Does the Primary Surgical Procedure Matter? | International Journal of Gynecological Cancer | 2009 | 153 |
| 45 | An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer | International Journal of Gynecological Cancer | 2006 | 151 |
| 46 | The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers - a study of the National Cancer Institute of Canada Clinical Trials Group | International Journal of Gynecological Cancer | 2004 | 149 |
| 47 | European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer | International Journal of Gynecological Cancer | 2017 | 149 |
| 48 | Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma | International Journal of Gynecological Cancer | 2012 | 148 |
| 49 | Different types of rupture of the tumor capsule and the impact on survival in early ovarian carcinoma | International Journal of Gynecological Cancer | 1994 | 147 |
| 50 | A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: Potential impact on treatment | International Journal of Gynecological Cancer | 2001 | 146 |
